From: In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis
Symptoms
Before Treatment
After Treatment
Drowsiness
38%
0%
Confusion
19%
Fatigue
58%
6.4%
Miscellaneous/Nonspecific
28%
9.6%